Cyclo Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $233 | $123 | $202 | $311 |
Gross Profit | 216 | -808 | -634 | -565 |
EBITDA | -8,287 | -5,635 | -5,107 | -5,637 |
EBIT | -8,289 | -5,637 | -5,109 | -5,681 |
Net Income | -8,832 | -5,981 | -4,343 | -5,642 |
Net Change In Cash | 233 | 123 | 202 | 311 |
Free Cash Flow | -12,040 | -3,848 | -6,182 | -4,297 |
Cash | 928 | 1,121 | 2,995 | 9,246 |
Basic Shares | 28,729 | 28,638 | 28,585 | 24,869 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,076 | $1,375 | $1,585 | $903 |
Gross Profit | -2,410 | 1,236 | 1,429 | 836 |
EBITDA | -20,030 | -15,602 | -14,269 | -8,948 |
EBIT | -20,050 | -15,621 | -14,286 | -8,961 |
Net Income | -20,057 | -15,279 | -14,305 | -8,923 |
Net Change In Cash | 1,076 | 1,375 | 1,585 | 903 |
Cost of Revenue | -15,069 | |||
Free Cash Flow | -16,187 | -15,129 | -15,027 | -8,593 |
Cash | 9,246 | 1,543 | 16,612 | 12,846 |
Basic Shares | 16,329 | 8,439 | 6,370 | 1,599 |
